Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)-a prospective single-arm interventional study.
Mikio Sugimoto; Takuma Kato; Yoichiro Tohi; Yosuke Shimizu; Ryuji Matsumoto; Takahiro Inoue; Yutaka Takezawa; Kimihiko Masui; Hiroshi Sasaki; Hiromi Hirama; Shiro Saito; Shin Egawa; Toshiyuki Kamoto; Satoshi Teramukai; Shinsuke Kojima; Takashi Kikuchi; Yoshiyuki Kakehi
BMC urology, 2022年09月14日, 査読有り